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Supplementary Note
Cochran-Armitage test of association
For a GWAS dataset, let Y i ∈ {0, 1} denote the indicator of disease status at the ith sample.
Let there be a total of N samples selected, with N 1 having been chosen from disease cases (Y i = 1) and N 0 having been chosen from disease controls (Y i = 0). Since this sampling is conditional upon case/control status, genotype frequencies may differ between our N samples and the whole population at disease associated SNPs. We therefore need to distinguish between which datasets the genotype probabilities are from; write P sam for probabilities computed for the samples (i.e. P sam (Y i = 1) = N 1 N ), and P for probabilities generated with reference to the whole population.
Let n be the total number of SNPs. For any SNP X, write G X i for its genotype coding ∈ {0, 1, 2} at sample i .
For the commonly used Cochran-Armitage test, the Z-Score at SNP X is computed as:
Where:
and V X , V Y are the variance of G X and Y respectively:
i.e.:
Under the null hypothesis of no association at SNP X, Z X is distributed as a standard normal. Hence the two-sided p-value at X is given by:
where Φ is the cumulative distribution function of the standard normal distribution. Conversely, given the unsigned p-value at X, the absolute value of the Z-Score is:
Allelic frequencies under a Causal Model
Write W = W 1 , ..., W m for the vector of causal SNPs. From phased publicly available reference datasets such as UK10K (?), it is possible to estimate haplotype frequencies across all SNPs in W at any subset of potential causal SNPs in control datasets. Since they are causal, these frequencies will differ in cases, and it is those frequencies we derive first. Note that, since sampling dependent only upon case/control status, we can assume:
Write γ 1 , ..., γ m for the log odds ratios of effect for the causal SNPs in the population. We assume that Y given G W can be modelled as a binomial logistic regression. Then, from (?), the sample-specific odds ratios are the same as those at the population-level, and we can write:
where γ 0 is an intercept parameter. Since GWAS sampling is retrospective, the proportion of cases in the sample is fixed at N 1 N , constraining γ 0 , which can be computed as follows:
Hence we can compute:
And also:
To derive genotype probabilities at SNPs in LD with the causal SNPs, we assume that LD structures do not differ between cases and controls, and hence the correlation between W and X is independent of both disease status and our sampling. Thus:
and we can estimate, for both the whole population, and for our sample:
from our reference dataset, for any constant a. From this, we compute:
By expanding out the numerator in terms of probabilities within the sample dataset, we see that:
And hence:
Estimation of Z Score for the causal model given by W and γ
Finding the true expectation of
is intractable, so instead we compute a first order approximation by assuming independence:
These terms can be computed as shown in the following sections.
We compute the expectation of U X in our sample as follows:
Using the expressions for E sam (G X i |Y i ) given in Section, this becomes:
Estimation of V X , the variance of G X , for the causal model given by W and γ
Recall:
This is tractable, however, we need to find E
, which is more complex.
V X is the variance of a normal, and so we model it as an Inverse Gamma (α, β) distribution.
X has a Γ(α, β −1 ) distribution, and V −1 X has a generalised gamma distribution with
Assuming we have computed E sam (V X ) and E sam (V 2 X ), α and β are completely specified as:
may be simply computed using:
Breaking this down into terms, for (i, j, k, l) representing different indices, we have:
Giving:
Thus, given only a choice of which SNPs are causal (W), their effect sizes (γ), sample sizes (N 0 , N 1 ) and a reference dataset from which we can derive allele frequencies (E(G X i |Y i = 0)) and the relationships between SNPs (E(G X i |G W i = w)), we can derive an expected Z Score, Z EXP at any SNP, causal or not.
This can then be used directly. However, most applications require simulated output from such a GWAS. Z SIM can therefore be computed, which will be distributed:
where Σ is the genotype correlation matrix for the SNPs in this region (?). The scenario label gives the corresponding "scenario-snp" pair -i.e. the label 3-1 refers to scenario 3, first causal SNP. Unlinked variants are denoted as SNP 0.Figure S2 : Results from simGWAS (sG) are similar to those from HAPGEN+SNPTEST (HG) and forward simulation (F). Distributions of simulated Z scores and log odds ratios are shown from 1000 simulations assuming 5000 cases and 5000 controls under two scenarios -4 and 5 -described in Table ? ?. The label of each plot gives the corresponding scenario-SNP pair, with SNP 0 unlinked (r 2 < 0.15) to either causal variants (no forward simulation results for SNP 0). In scenarios 4 and 5, two SNPs have the same effect sizes but are either weakly linked (r = 0.15, scenario 4) or in strong LD (r = 0.8, scenario 5). Note that the marginal effect sizes are closer to 0 in scenario 5 because the linked effects cancel when considering marginal association.
